Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 6 EP applications Carin Marie Lisa Ribard has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12721529

USE OF ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE ANTIBODY FOR THE TREATMENT OF B-CELL MALIGNANCIES SYMPTOMS

IPC classification:
A61K 47/48, C07K 16/28
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi, S.A.
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
EXAMINATION IN PROGRESS
EP12728522

PROCESS FOR PREPARING GENETICALLY TRANSFORMED YEASTS CAPABLE OF PRODUCING A MOLECULE OF INTEREST AT A HIGH TITRE

IPC classification:
C12N 9/02, C12N 9/04, C12N 15/52, C12N 15/81, C12P 33/00
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
GRANT OF PATENT INTENDED
EP12740174

COMBINATION THERAPY FOR THE TREATMENT OF CD19+ B-CELL MALIGNANCIES SYMPTOMS COMPRISING AN ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE AND RITUXIMAB

IPC classification:
A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi, S.A.
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
GRANT OF PATENT INTENDED
EP13710362

A MIXTURE OF POLAR GLYCOLIPIDS FOR USE IN THE TREATMENT OF PAIN AND COPD

IPC classification:
A61K 31/739, A61K 35/74, A61P 11/00, A61P 29/00, C08B 37/00, C12P 19/04, C12R 1/89
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
PATENT GRANTED
EP14717073

IMMUNO IMAGING AGENT FOR USE WITH ANTIBODY-DRUG CONJUGATE THERAPY

IPC classification:
C07K 16/30, C07K 16/46
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
The patent has been granted
EP15702160

NOVEL CYTOCHROME P450 POLYPEPTIDE WITH INCREASED ENZYMATIC ACTIVITY

IPC classification:
C07K 14/435
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature